Tissue-engineered heart valve scaffolds

Annals of Thoracic and Cardiovascular Surgery

Volumn 15, Issue 6, 2009, Pages 362-367

  Dohmen, Pascal M ^a   Konertz, Wolfgang ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; TISSUE SCAFFOLD;

ANIMAL; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INSTRUMENTATION; PROSTHESIS; REVIEW; TISSUE ENGINEERING; VALVULAR HEART DISEASE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 74249098036     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Murray G. Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology 1956; 7: 466-71.
2. Gall KL, Smith SE, Willmette CA, O'Brien MF. Allograft heart valve viability and valve-processing variables. Ann Thorac Surg 1998; 65: 1032-8.
3. da Costa FD, Dohmen PM, Duarte D, von Glenn C, Lopes SV, et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross procedure. Eur J Cardiothorac Surg 2005; 27: 572-8.
4. Affonso da Costa FD, Dohmen PM, Lopes SV, Lacerda G, Pohl F, et al. Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. Artif Organs 2004; 28: 366-70.
5. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, et al. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999; 11 (4 Suppl 1): 194-200.
6. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998; 115: 118-27.
7. Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001; 13 (4 Suppl 1): S87-92.
8. Allen DJ, DiDio LJ, Zacharias A, Fentie I, McGrath AJ, et al. Microscopic study of normal parietal pericardium and unimplanted Puig-Zerbini pericardial valvular heterografts. J Thorac Cardiovasc Surg 1984; 87: 845-55.
9. Bengtsson L, Radegran K, Haegerstrand A. In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells. Eur J Cardiothorac Surg 1993; 7: 393-8.
10. Herzog C, Salès N, Etchegaray N, Charbonnier A, Freire S, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004; 363: 422-8.
11. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Eng J Med 2003; 349: 1812-20.
12. Wilson CA. Porcine endogenous retroviruses and xenotransplantation. Cell Mol Life Sci 2008; 65: 3399-412.
13. Erdbrügger W, Konertz W, Dohmen PM, Posner S, Ellerbrok H, et al. Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Eng 2006; 12: 2059-68.
14. Schoof PH, Gittenberger-De Groot AC, De Heer E, Bruijn JA, Hazekamp MG, et al. Remodeling of the porcine pulmonary autograft wall in the aortic position. J Thorac Cardiovasc Surg 2000; 120: 55-65.
15. Chambers JC, Somerville J, Stone S, Ross DN. Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. Circulation 1997; 96: 2206-14.
16. Dohmen PM, da Costa F, Holinski S, Lopes SV, Yoshi S, et al. Is there a possibility for a glutaraldehyd-free porcine heart valve to grow? Eur Surg Res 2006; 38: 54-61.
17. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995; 60 (6 Suppl): S513-6.
18. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, et al. Tissue engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996; 94 (9 Suppl): 2164-8.
19. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998; 115: 536-46.
20. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001; 55: 141-50.
21. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, et al. Early in vivo experience with tissue engineered trileaflet heart valves. Circulation 2000; 102 (19 Suppl 3): 322-9.
22. Sodian R, Sperling JS, Martin DP, Egozy A, Stock U, et al. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng 2000; 6: 183-8.
23. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000; 102 (19 Suppl 3): 344-9.
24. Pankajakshan D, Krishnan LK. Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering. Artif Organs 2009; 33: 16-25.
25. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006; 113: 1344-52
26. Thubrikar MJ, Nolan SP, Aouad J, Deck JD. Stress sharing between the sinus and leaflets of canine aortic valve. Ann Thorac Surg 1986; 42: 434-40.
27. Grande KJ, Cochran RP, Reinhall PG, Kunzelman KS. Mechanism of aortic valve incompetence: finite element modeling of aortic root dilatation. Ann Thorac Surg 2000; 69: 1851-7.
28. Cox JL, Ad N, Myers K, Gharib M, Quijano RC. Tubular heart valves: a new tissue prosthesis design-preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg 2005; 130: 520-7.
29. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23: 47-55.
30. Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, et al. Midterm clinical results using a tissue- engineered pulmonary valve to reconstruct the right ventricular outflow tract during Ross procedure. Ann Thorac Surg 2007; 84: 729-36.
31. Leyh RG, Wilhelmi M, Rebe P, Fischer S, Kofidis T, et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg 2003; 75: 1457-63.
32. Simpson E. Minor transplantation antigens: animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions. Transplantation 1998; 65: 611-6.
33. Martin U, Kiessig V, Blusch JH, Haverich A, von der Helm K, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-4.
34. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunogenecity of collagen. J Biomed Mater Res B Appl Biomater 2004; 71: 343-54.
35. Nakamura T. Clinical application of nerve conduits consisting of a polyglycolic acid (PGA)-collagen composite tube filled with collagen sponge. Connective Tissue 2003; 35: 53-7.
36. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, et al. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998; 72: 3082-7.
37. Weiss RA. Transgenic pigs and virus adaption. Nature 1988; 391: 327-8.
38. Knight R, Collins S. Human prion disease: cause, clinical and diagnostic aspects. Contrib Microbiol 2001; 7: 68-92.
39. Leyh RG, Wilhelmi M, Walles T, Kallenbach K, Rebe P, et al. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross- species transmission of porcine endogenous retrovirus. J Thoracic Cardiovascular Surg 2003; 126: 1000-4.
40. Seddon AM, Curnow P, Booth PJ. Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 2004; 1666 (1-2): 105-17.
41. Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, et al. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 2005; 27: 566-71.
42. Gulik-Krzywicki T. Structural studies of the associations between biological membrane components. Biochim Biophys Acta 1975; 415: 1-28.
43. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, et al. Tissue engineering of cardiac valve prostheses I: development and histological characteriza- tion of an acellular porcine scaffold. J Heart Valve Dis 2002; 11: 457-62.
44. Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Weigel G, et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003; 26: 421-7.
45. Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004; 127: 399-405.
46. Woods T, Gratzer PF. Effectiveness of three extraction techniques in the development of a decellularized bone- anterior cruciate ligament-bone graft. Biomaterials 2005; 26: 7339-49.
47. Klebe RJ. Isolation of a collagen-dependent cell attachment factor. Nature 1974; 250: 248-51.
48. Moore R, Madara JL, MacLeod RJ. Enterocytes adhere preferentially to collagen IV in a differentially regulated divalent cation-dependent manner. Am J Physiol 1994; 266 (6 Pt 1): G1099-107.
49. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7.
50. Tarone G, Galetto G, Prat M, Comoglio PM. Cell surface molecules and fibronectin-mediated cell adhesion: effect of proteolytic digestion of membrane proteins. J Cell Biol 1982; 94: 179-86.
51. Schenke-Layland K, Vasilevski O, Opitz F, König K, Riemann I, et al. Impact of decellularization of xenogenic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003; 143: 201-8.
52. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 2002; 74: 1438-42.
53. Dohmen PM, Gabbieri D, Lembcke A, Konertz W. Endothelial cell seeded bovine internal mammary artery for complete revascularization. Ann Thorac Surg 2007; 83: 1168-9.
54. Barnes RW, Rittenhouse EA, Mohri H, Merendino KA. A clinical experience with the ββ-propiolactonesterilized homologous aortic valve followed up to four years. J Thorac Cardiovasc Surg 1970; 59: 785-93.
55. Cohen DJ, Myerowitz PD, Young WP, Chopra PS, Berkoff HA, et al. The fate of aortic valve homografts 12 to 17 years after implantation. Chest 1988; 93: 482-4.
56. Beach PM Jr, Bowman FO Jr, Kaiser GA, Parodi E, Malm JR. Aortic valve replacement with frozen irradiated homografts. Long-term evaluation. Circulation 1972; 45 (1 Suppl): I29-35.